Drugs / Novo Rapid Insulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01149005 | Jun 2010 → Jun 2015 | cystic fibrosis, glucose intolerance, lung disorder | Hadassah Medical Organization | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novo Rapid Insulin | “Novo Rapid Insulin (Novonordisk)” NCT01149005 ↗ |
| Modality | Protein / enzyme biologic | “short acting insulin” NCT01149005 ↗ |
| Route | Subcutaneous | “1-4 units will be injected Subcutaneously (SC), before every main meal.” NCT01149005 ↗ |